Ownership history in MORGAN STANLEY · 26 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 339,922 | -353,334 | -51.0% | 0.00% | $16.1M | — |
| 2025 Q2 | REDUCED | 693,256 | -109,598 | -13.7% | 0.00% | $37.0M | — |
| 2025 Q1 | ADDED | 802,854 | +331,319 | +70.3% | 0.00% | $32.5M | — |
| 2024 Q4 | ADDED | 471,535 | +23,465 | +5.2% | 0.00% | $13.1M | — |
| 2024 Q3 | REDUCED | 448,070 | -498,458 | -52.7% | 0.00% | $12.9M | — |
| 2024 Q2 | ADDED | 946,528 | +542,665 | +134.4% | 0.00% | $22.2M | — |
| 2024 Q1 | REDUCED | 403,863 | -653,464 | -61.8% | 0.00% | $10.2M | — |
| 2023 Q4 | ADDED | 1,057,327 | +617,591 | +140.4% | 0.00% | $24.7M | — |
| 2023 Q3 | ADDED | 439,736 | +54,078 | +14.0% | 0.00% | $22.2M | — |
| 2023 Q2 | ADDED | 385,658 | +28,065 | +7.8% | 0.00% | $18.0M | — |